C. O. Kangani et al. / Tetrahedron Letters 47 (2006) 6497–6499
6499
Vorbruggen, H.; Krolikiewicz, K. Tetrahedron 1993, 49,
9353–9372.
¨
In conclusion, we have developed an efficient, straight-
forward and common method for the synthesis of oxaz-
olines, benzoxazoles, and oxadiazoles from various
carboxylic acids using the Deoxo-Fluor reagent. The
reaction is carried out in one-pot and is operationally
simple, mild, and gives products with high yields and
purity. Moreover, short reaction times, ease of
work-up and high degree of chemoselectivity are other
noteworthy advantages of this new method.
10. (a) Kamata, K.; Agata, I. J. Org. Chem. 1998, 63, 3113–
3116; (b) Jnaneshwara, G. K.; Deshpande, V. H.;
Lalithambika, M.; Ravindranathan, T.; Bedekar, A. V.
Tetrahedron Lett. 1998, 39, 459–462; (c) Clarke, D. S.;
Wood, R. Synth. Commun. 1996, 26, 1335–1340; (d)
Oussaid, B.; Berlan, J.; Soufiaoui, M.; Garrigues, B.
Synth. Commun. 1995, 25, 659–665; (e) Katritzky, A. R.;
Cai, C.; Suzuki, K.; Singh, S. K. J. Org. Chem. 2004, 69,
811–814.
11. (a) Wipf, P.; Venkatraman, S. Tetrahedron Lett. 1996, 37,
4659–4662; (b) Phillips, A. J.; Uto, Y.; Wipf, P.; Reno, M.
J.; Williams, D. R. Org. Lett. 2000, 2, 1165–1168; (c)
Bunnage, M. E.; Davies, S. G.; Goodwin, C. J. J. Chem.
Soc., Perkin Trans. 1 1994, 17, 2385–2391; (d) Wuts, P. G.
M.; Northuis, J. M.; Kwan, T. A. J. Org. Chem. 2000, 65,
9223–9225.
12. (a) Yale, H. L.; Losee, K. J. Med. Chem. 1966, 9, 478–
483; (b) Al-Talib, M.; Tashtoush, H.; Odeh, N. Synth.
Commun. 1990, 20, 1811–1817; (c) Kerr, V. N.; Ott, D.
G.; Hayes, F. N. J. Am. Chem. Soc. 1960, 82, 186–189;
(d) Liras, S.; Allen, M. P.; Segelstein, B. E. Synth.
Commun. 2000, 30, 437–443; (e) Tully, W. R.; Gardner,
C. R.; Gillespie, R. J.; Westwood, R. J. Med. Chem.
1991, 34, 2060–2067; (f) Balachandran, K. S.; George,
M. V. Tetrahedron 1973, 29, 2119–2128; (g) Chiba, T.;
Okimoto, M. J. Org. Chem. 1992, 57, 1375–1379; (h)
Yang, R.; Dai, L. J. Org. Chem. 1993, 58, 3381–
3383.
Acknowledgments
This investigation was supported by funding from
National Institutes of Health, NIDDK (DK046204),
and by the University of Pittsburgh Obesity and Nutri-
tion Research Center (DK46204).
References and notes
1. Gant, T. G.; Meyers, A. I. Tetrahedron 1994, 50, 2297–
2360, and references cited therein.
2. Wang, Y.; Sauer, D. R.; Djuric, S. W. Tetrahedron Lett.
2006, 47, 105–108.
3. (a) Li, Q.; Woods, K. W.; Claiborne, A.; Gwaltney, S. L.,
II; Barr, K. J.; Liu, G.; Gehrke, L.; Credo, R. B.; Hua
Hui, Y.; Lee, J.; Warner, R. B.; Kovar, P.; Nukkala, M.
A.; Zielinski, N. A.; Tahir, S. K.; Fitzgerald, M.; Kim, K.
H.; Marsh, K.; Frost, D.; Ng, S.-C.; Rosenberg, S.;
Fattorusso, C.; Catalanotti, B.; Ramunno, A.; Nacci, V.;
Novellino, E.; Grewer, C.; Ionescu, D.; Rauen, T.;
Griffiths, R.; Sinclair, C.; Fumagalli, E.; Mennini, T. J.
Med. Chem. 2001, 44, 2507–2510; (b) Rodriguez, A. D.;
Ramirez, C.; Rodriguez, I. I.; Gonzalez, E. Org. Lett.
1999, 1, 527–530; (c) Wipf, P.; Venkatraman, S. Synlett
1997, 1–10.
13. (a) Tandon, V. K.; Chhor, R. B. Synth. Commun.
2001, 31, 1727–1732; (b) Mashraqui, S. H.; Ghadigaon-
kar, Sh. G.; Kenny, R. S. Synth. Commun. 2003, 33,
2541–2545; (c) Bentiss, F.; Lagrenee, M.; Barbry, D.
Synth. Commun. 2001, 31, 935–938; (d) Wang, Y.;
Sauer, D. R.; Djuric, S. W. Tetrahedron Lett. 2006, 47,
105–108.
14. Kangani, C. O.; Kelley, D. E. Tetrahedron Lett. 2005, 46,
8917–8920.
15. According to the literature bis(methoxyethyl)amine is
generated along with SO2, in acyl fluoride formation
using the Deoxo-Fluor reagents, see: White, J. M.;
Tunoori, A. R.; Turunen, B. J.; Georg, G. I. J. Org.
Chem. 2004, 69, 2573–2576.
4. (a) Johns, B. A. PCT Int Appl. WO 2004101512; (b)
Piatnitski, E.; Kiselyov, A.; Doody, J.; Hadari, Y.;
Ouyang, S.; Chen, X. PCT Int Appl. WO 2004052280.
5. (a) Wipf, P.; Wang, X. Org. Lett. 2002, 4, 1197–1200; (b)
´
Gomez, M.; Muller, G.; Rocamora, M. Coord. Chem. Rev.
16. Representative procedure: The elaidic acid (49.4 mg,
0.175 mmol, 1 equiv), diisopropylethylamine (DIPEA)
(80 lL, 0.46 mmol, 2.6 equiv), 2-aminophenol (42.10 mg,
0.385 mmol, 2.2 equiv), and potassium carbonate (K2CO3)
(excess) were dissolved in 2 mL CH2Cl2. The solution was
cooled to 0 ꢁC, and the Deoxo-Fluor reagent (71 lL,
0.385 mmol, 2.2 equiv) was added dropwise. After 2 h the
reaction mixture was quenched with saturated aqueous
sodium bicarbonate at 0 ꢁC. After warming to room
temperature, the biphasic mixture was extracted with
CH2Cl2. The combined organic extracts were dried
(MgSO4), filtered, and concentrated in vacuo. Flash
column chromatography (silica gel, 1.5 · 20 cm, 10 ! 50
EtOAc/hexanes) provided 9 (60.3 mg, 97%) as a light
yellow solid.
17. Shimadzu HPLC (Model LC-10AT vp); Waters UV
detector (Model 486); Chiralcel OD column; 15% 2-
propanol–hexane; 0.5 mL minꢀ1; at a stable ambient
temperature (21 ꢁC) were used.
18. GC–MS analysis of the crude cyclized products 1,3,4-
oxadiazoles as well oxazolines and benzoxazoles showed
that the products generally were P90% pure.
1999, 193–195, 769–835; (c) Meyers, A. I. J. Heterocycl.
Chem. 1998, 35, 991–1001.
6. (a) Corey, E. J.; Ishihara, K. Tetrahedron Lett. 1992, 33,
6807; (b) Reuman, M.; Meyers, A. I. Tetrahedron 1985, 41,
837–860; (c) Meyers, A. I.; Miheich, E. D. Angew. Chem.,
Int. Ed. Engl. 1976, 270.
7. Green, T. W.; Wuts, P. G. M. Protective Groups in Organic
Synthesis, 2nd ed.; John Wiley & Sons, 1991; pp 265–266
and 433–436.
8. (a) Palaska, E.; Sahin, G.; Kelicen, P.; Durlu, N. Tugba.;
Altinok, G. IL Farmaco 2002, 57, 101–107; (b) Dogan, H.
N.; Duran, A.; Rollas, S.; Sener, G.; Uysal, M. K.; Gulen,
D. Bioorg. Med. Chem. 2002, 10, 2893–2898; (c) Adelstein,
G. W.; Yen, Ch. H.; Dajani, E. Z.; Bianchi, R. G. J. Med.
Chem. 1976, 19, 1221–1225; (d) Brown, P.; Best, D. J.;
Broom, N. J. P.; Cassels, R.; O’Hanlon, P. J.; Mitchell, T.
J.; Osborne, N. F.; Wilson, J. M. J. Med. Chem. 1997, 40,
2563–2570.
9. (a) Bandgar, B. P.; Pandit, S. S. Tetrahedron Lett. 2003,
44, 2331–2333; (b) Cwik, A.; Hell, Z.; Hegedus, A.; Finta,
Z.; Horvath, Z. Tetrahedron Lett. 2002, 43, 3985–3987; (c)
¨
´